Neurocrine Biosciences NBIX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's pre-tax income?
- Neurocrine Biosciences (NBIX) reported pre-tax income of $246.8M in Q1 2026.
- How has Neurocrine Biosciences's pre-tax income changed year-over-year?
- Neurocrine Biosciences's pre-tax income increased by 1578.9% year-over-year, from $14.7M to $246.8M.
- What is the long-term trend for Neurocrine Biosciences's pre-tax income?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's pre-tax income has grown at a 48.8% compound annual growth rate (CAGR), from $213.9M to $705.4M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.